Secure surveillance of antimicrobial resistant organism colonization or infection in Ontario long term care homes

PLoS One. 2014 Apr 8;9(4):e93285. doi: 10.1371/journal.pone.0093285. eCollection 2014.

Abstract

Background: There is stigma attached to the identification of residents carrying antimicrobial resistant organisms (ARO) in long term care homes, yet there is a need to collect data about their prevalence for public health surveillance and intervention purposes.

Objective: We conducted a point prevalence study to assess ARO rates in long term care homes in Ontario using a secure data collection system.

Methods: All long term care homes in the province were asked to provide colonization or infection counts for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and extended-spectrum beta-lactamase (ESBL) as recorded in their electronic medical records, and the number of current residents. Data was collected online during the October-November 2011 period using a Paillier cryptosystem that allows computation on encrypted data.

Results: A provably secure data collection system was implemented. Overall, 82% of the homes in the province responded. MRSA was the most frequent ARO identified at 3 cases per 100 residents, followed by ESBL at 0.83 per 100 residents, and VRE at 0.56 per 100 residents. The microbiological findings and their distribution were consistent with available provincial laboratory data reporting test results for AROs in hospitals.

Conclusions: We describe an ARO point prevalence study which demonstrated the feasibility of collecting data from long term care homes securely across the province and providing strong privacy and confidentiality assurances, while obtaining high response rates.

MeSH terms

  • Enterococcus / drug effects
  • Enterococcus / isolation & purification*
  • Humans
  • Infection Control
  • Long-Term Care*
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Nursing Homes
  • Ontario
  • Staphylococcal Infections / epidemiology*
  • Vancomycin Resistance*
  • beta-Lactam Resistance*

Grants and funding

The funders for this project were: (1) The Canada Research Chairs program through a research grant. (2) The Ontario Institute for Cancer Research through a research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.